- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03010150
Blodprover och frågeformulär för att studera efterlevnaden av förebyggande sväljövningar hos deltagare med metastaserad huvud- och nackcancer
Modellerande efterlevnad av förebyggande sväljningsövningar vid huvud- och nackcancer
This trial uses blood tests and questionnaires to study how well participants with head and neck cancer that has spread to other places in the body adhere to swallowing exercises to prevent future disease. Using blood tests to study cytokines (proteins related to the immune system) may help doctors learn if certain levels of cytokines affect whether or not side effects occur and if they put participants at risk for future disease. Questionnaires may help doctors learn about the reasons head and neck cancer participants may or may not follow the swallowing exercises that they are asked to perform after receiving radiation treatments.
Studieöversikt
Status
Betingelser
- Kliniskt stadium III HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Steg III Hypofarynxkarcinom AJCC v8
- Steg III Larynxcancer AJCC v8
- Steg III Orofaryngeal (p16-negativ) karcinom AJCC v8
- Steg IV Hypofarynxkarcinom AJCC v8
- Steg IV Larynxcancer AJCC v8
- Steg IV Orofaryngeal (p16-negativ) karcinom AJCC v8
- Kliniskt stadium I HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Kliniskt stadium II HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Patologiskt stadium I HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Patologiskt stadium II HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Steg IV Nasofaryngealt karcinom AJCC v8
- Patologiskt stadium III HPV-medierat (p16-positivt) orofarynxkarcinom AJCC v8
- Steg IVA Nasofaryngealt karcinom AJCC v8
- Steg IVB Nasofaryngealt karcinom AJCC v8
- Stadium IVA Hypofarynxkarcinom AJCC v8
- Steg IVA Larynxcancer AJCC v8
- Stadium IVA Orofaryngeal (p16-negativ) karcinom AJCC v8
- Steg IVB Hypofarynxkarcinom AJCC v8
- Steg IVB Larynxcancer AJCC v8
- Steg IVB Orofaryngeal (p16-negativ) karcinom AJCC v8
- Metastaserande huvud- och halskarcinom
- Karcinom hos okänd primär
- Metastatisk malign neoplasm i livmoderhalsen
- Steg I Hypofarynxkarcinom AJCC v8
- Steg I Nasofaryngealt karcinom AJCC v8
- Steg II Hypofarynxkarcinom AJCC v8
- Steg II Larynxcancer AJCC v8
- Steg II Nasofaryngealt karcinom AJCC v8
- Steg II Orofaryngeal (p16-negativ) karcinom AJCC v8
- Steg III Nasofarynxkarcinom AJCC v8
Intervention / Behandling
Detaljerad beskrivning
PRIMARY OBJECTIVES:
I. To determine whether illness perceptions significantly predict adherence to swallowing exercises at 6 months after the end of radiation.
II. To determine whether sickness behaviors (depression, fatigue, pain)'s effect on illness perceptions are mediated by pro-inflammatory cytokines.
III. To determine whether social support moderates the impact of coping on appraisal of coping.
SECONDARY OBJECTIVES:
I. As a secondary aim, to determine the feasibility and utility of cardiac impedance pre-ejection period measurement as a corollary measure for depression and distress.
II. As a secondary aim, to identify potential genetic markers for swallowing dysfunction which has developed by the 6-month follow-up.
OUTLINE:
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection.
After completion of study, participants are followed up periodically for up to 2 years.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- Rekrytering
- M D Anderson Cancer Center
-
Kontakt:
- Eileen H. Shinn
- Telefonnummer: 713-745-0870
-
Huvudutredare:
- Eileen H. Shinn
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Participants with head and neck cancer
Beskrivning
Inclusion Criteria:
- Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
- Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
- Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
- Are stage II-IVb for laryngeal cancer
- Are stage I-IVb for hypopharyngeal
- Are stage I-IVb for nasopharyngeal cancer
- Have stage I-III unknown primary cancer with cervical
Exclusion Criteria:
- Have other cancer diagnoses, except non-melanoma skin cancer
- Had treatment for previous head and neck cancer or radiation to the head and neck
- Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
- Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Observational (blood tests, questionnaires)
Participants provide blood samples prior to and at the 6-month visit after receiving radiation therapy. Participants also complete questionnaires either at home, in clinic, or via internet over 30 minutes prior to receiving radiation therapy and within 14 days of blood sample collection. |
Ancillary studies Provide blood samples |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Adherence to swallowing exercises
Tidsram: Up to 6 months
|
The primary analytic approach is to use linear mixed models to determine whether illness perceptions significantly predict adherence 6 months. The study will estimate and test the illness perception subscale scores' relationship to adherence using a linear mixed model. In the model, the dependent variable is the patient's self-reported adherence score and independent variables include illness perception, follow-up assessment time point and other covariates such as demographic and medical variables, depression, pain, fatigue, emotional coping, objective coping, appraisal of coping, stress, and lack of social well-being. |
Up to 6 months
|
|
Illness perceptions
Tidsram: Up to 6 months
|
The study's statistical tool is mediation analysis: the independent variables are the sickness behaviors (depression, fatigue, pain); the mediators are the cytokine levels, and the outcome variable is illness perception. The study will test the mediator effects based on the product of coefficients method, rather than the classical Baron & Kenny causal steps tests, since the former approach has better statistical power. The study will conduct both single-mediator analysis for each of the mediators, and multiple-mediator analysis with all mediators in the mediating process |
Up to 6 months
|
|
Effect of social support on coping
Tidsram: Up to 6 months
|
The moderating effect of social support on coping and appraisal of coping is the statistical equivalent of testing the two-way interaction between these variables and the social support variable. Multivariate linear regression will be used, in which the dependent variable is appraisal of coping at 6 months follow-up, and independent variables include the emotion-focused coping and action-focused sub scales, social support, and their two-way interactions. In the regression, the study will control for baseline variables. In addition, we will also apply the linear mixed model to investigate the moderating effect of these variables longitudinally. The mixed model naturally accounts for the correlation of repeated measures at baseline and 6 months follow-up. |
Up to 6 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Eileen H Shinn, M.D. Anderson Cancer Center
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Beräknad)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Stomatogena sjukdomar
- Patologiska processer
- Neoplasmer efter plats
- Neoplasmer
- Luftvägssjukdomar
- Neoplasmer efter histologisk typ
- Neoplasmer i huvud och hals
- Neoplasmer, körtel och epitel
- Neoplasmer i andningsvägarna
- Neoplastiska processer
- Otorhinolaryngologiska sjukdomar
- Faryngeala neoplasmer
- Otorhinolaryngologiska neoplasmer
- Nasofaryngeala sjukdomar
- Faryngeala sjukdomar
- Larynxsjukdomar
- Neoplasma Metastas
- Nasofaryngeala neoplasmer
- Patologiska tillstånd, tecken och symtom
- Nasofaryngealt karcinom
- Carcinom
- Laryngeala neoplasmer
- Orofaryngeala neoplasmer
- Neoplasmer, okänd primär
- Hypofaryngeala neoplasmer
Andra studie-ID-nummer
- 2016-0597
- 2016-0597 (Annan identifierare: M D Anderson Cancer Center)
- NCI-2018-01260 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))
- R21DE019954 (U.S.S. NIH-anslag/kontrakt)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .